Host: |
Rabbit |
Applications: |
WB/IHC/IF/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Keratin, type I cytoskeletal 13 (233-282 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000IHC 1:100-1:300ELISA 1:5000IF 1:50-200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
KRT13 |
Gene ID: |
3860 |
Uniprot ID: |
K1C13_HUMAN |
Immunogen Region: |
233-282 aa |
Specificity: |
Cytokeratin 13 Polyclonal Antibody detects endogenous levels of Cytokeratin 13 protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human Cytokeratin 13 at the amino acid range 233-282 |
Post Translational Modifications | O-glycosylated.glycans consist of single N-acetylglucosamine residues. |
Function | Type 1 keratin (Probable). Maintains postnatal tongue mucosal cell homeostasis and tissue organization in response to mechanical stress, potentially via regulation of the G1/S phase cyclins CCNE1 and CCNE2. |
Protein Name | Keratin - Type I Cytoskeletal 13Cytokeratin-13Ck-13Keratin-13K13 |
Database Links | Reactome: R-HSA-6805567Reactome: R-HSA-6809371 |
Alternative Antibody Names | Anti-Keratin - Type I Cytoskeletal 13 antibodyAnti-Cytokeratin-13 antibodyAnti-Ck-13 antibodyAnti-Keratin-13 antibodyAnti-K13 antibodyAnti-KRT13 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance